Concepedia

Eirinaios I. Vrettos

EI

6

Publications

172

Citations

6

H-Index

2017

Active since

Affiliations

University of Ioannina(Current)

National and Kapodistrian University of Athens

Biomedical Research Foundation of the Academy of Athens

Imperial College London

Theageneio General Hospital

Eirinaios I. Vrettos is an author at University of Ioannina specializing in medicine, drug discovery, and pharmacology.

ORCID

Top concepts

Publications per year

2017–2020

6

Publications

6

Unveiling and tackling guanidinium peptide coupling reagent side reactions towards the development of peptide-drug conjugates

Eirinaios I. Vrettos, Nisar Sayyad, Eftychia M. Mavrogiannaki et al. · RSC Advances · 2017 · 41 citations · Full text

, , +15

Development of programmable gemcitabine-GnRH pro-drugs bearing linker controllable “click” oxime bond tethers and preclinical evaluation against prostate cancer

Eirinaios I. Vrettos, Theodoros Karampelas, Nisar Sayyad et al. · European Journal of Medicinal Chemistry · 2020 · 31 citations · Full text

, , +8

Enhancement of glioblastoma multiforme therapy through a novel Quercetin-Losartan hybrid

Antonis D. Tsiailanis, Alexander Renziehausen, Sofia Kiriakidi et al. · Free Radical Biology and Medicine · 2020 · 30 citations

, , +11

Rational design and structure–activity relationship studies of quercetin–amino acid hybrids targeting the anti-apoptotic protein Bcl-xL

Tahsin F. Kellici, Μaria V. Chatziathanasiadou, Min‐Sung Lee et al. · Organic & Biomolecular Chemistry · 2017 · 28 citations

Development of bioactive gemcitabine-D-Lys6-GnRH prodrugs with linker-controllable drug release rate and enhanced biopharmaceutical profile

Nisar Sayyad, Eirinaios I. Vrettos, Theodoros Karampelas et al. · European Journal of Medicinal Chemistry · 2019 · 27 citations · Full text

, , +9

Rows per page

1–5 of 6